Adam P. Dicker
Experienced in Head and Neck Squamous Cell Carcinoma (HNSCC)

Dr. Adam P. Dicker

Radiation Oncology | Oncology
111 South 11th Street, Suite G-301, 
Philadelphia, PA 
Accepting New Patients
Experienced in Head and Neck Squamous Cell Carcinoma (HNSCC)
111 South 11th Street, Suite G-301, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adam Dicker is an Oncologist and a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Dicker is rated as an Experienced provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Gliomatosis Cerebri, Glioblastoma, and Prostatectomy. Dr. Dicker is currently accepting new patients.

His clinical research consists of co-authoring 258 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 2 clinical trials in the study of Head and Neck Squamous Cell Carcinoma (HNSCC).

Graduate Institution
Weill Cornell Medical College
Residency
Memorial Sloan-Kettering Cancer Center
Specialties
Radiation Oncology
Oncology
Licenses
Radiology in PA
Board Certifications
Radiology
Radiation Oncology
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Hebrew
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 5 Less Insurance Carriers -

Locations

Radiation Oncology at Thomas Jefferson University Hospital
111 South 11th Street, Suite G-301, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Dicker has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Brain Tumor
Arteriovenous Malformation
Bladder Cancer
Acoustic Neuroma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase Ib Trial of Enzalutamide in Combination With Radiation Therapy and LHRH Agonist Therapy in the Management of Intermediate and High-Risk Prostate Cancer
Phase Ib Trial of Enzalutamide in Combination With Radiation Therapy and LHRH Agonist Therapy in the Management of Intermediate and High-Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Drug, Radiation
Study Drugs: Enzalutamide, Goserelin Acetate, Leuprolide Acetate
Study Phase: Phase 1
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Radiation, Other, Procedure
Study Phase: Phase 1
A Feasibility Pilot Trial Evaluating Caloric Restriction for Oncology Research in Early Stage Breast Cancer Patients
A Feasibility Pilot Trial Evaluating Caloric Restriction for Oncology Research in Early Stage Breast Cancer Patients
Enrollment Status: Completed
Publish Date: June 06, 2025
Intervention Type: Behavioral, Radiation, Procedure, Other
Study Phase: Not Applicable
TELEPORT STUDY: A Pilot Feasibility Trial Examining The Use of Telehealth in Post Radiation Therapy Visits
TELEPORT STUDY: A Pilot Feasibility Trial Examining The Use of Telehealth in Post Radiation Therapy Visits
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Other
Study Phase: Not Applicable
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Radiation, Drug
Study Drug: MK-3475
Study Phase: Phase 1
A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers
A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Other
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 1
A Pilot Feasibility Trial Examining the Use of Electronic Patient-Reported Outcomes in Prostate Cancer Patients With Apple ResearchKit Smartphone Application
A Pilot Feasibility Trial Examining the Use of Electronic Patient-Reported Outcomes in Prostate Cancer Patients With Apple ResearchKit Smartphone Application
Enrollment Status: Terminated
Publish Date: April 29, 2025
Intervention Type: Other
View 7 Less Clinical Trials

258 Total Publications

RadOncRAG: A Novel Retrieval-Augmented Generation Framework Improves Large Language Model Benchmark Performance in Radiation Oncology.
RadOncRAG: A Novel Retrieval-Augmented Generation Framework Improves Large Language Model Benchmark Performance in Radiation Oncology.
Journal: JCO clinical cancer informatics
Published: November 14, 2025
Similar Doctors
Elite in Head and Neck Squamous Cell Carcinoma (HNSCC)
Dr. Roger B. Cohen
Oncology
Elite in Head and Neck Squamous Cell Carcinoma (HNSCC)
Dr. Roger B. Cohen
Oncology

Abramson Cancer Center Perelman 2nd Floor West

3400 Civic Center Boulevard, West Pavilion, 2nd Floor, 
Philadelphia, PA 
 (1.8 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Roger Cohen is an Oncologist in Philadelphia, Pennsylvania. Dr. Cohen is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tissue Biopsy, and Endoscopy. Dr. Cohen is currently accepting new patients.

Distinguished in Head and Neck Squamous Cell Carcinoma (HNSCC)
Dr. Jonathan D. Cheng
Oncology | Transplant Surgery
Distinguished in Head and Neck Squamous Cell Carcinoma (HNSCC)
Dr. Jonathan D. Cheng
Oncology | Transplant Surgery
333 Cottman Ave, Fox Chase Cancer Center, 
Philadelphia, PA 
 (9.1 miles away)
215-728-6900
Languages Spoken:
English
See accepted insurances

Jonathan Cheng is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Cheng is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Cancer, Familial Pancreatic Cancer, and Pancreatoblastoma.

Rita S. Axelrod
Distinguished in Head and Neck Squamous Cell Carcinoma (HNSCC)
Dr. Rita S. Axelrod
Oncology
Distinguished in Head and Neck Squamous Cell Carcinoma (HNSCC)
Dr. Rita S. Axelrod
Oncology

Jefferson Cancer - Honickman Center

1101 Chestnut Street, Floor 14, 
Philadelphia, PA 
 (0.1 miles away)
215-955-8874
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rita Axelrod is an Oncologist in Philadelphia, Pennsylvania. Dr. Axelrod is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Axelrod is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dicker's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile